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The natural history of cow’s milk allergy is usually
benign. Among non-IgE mediated forms, proctocolitis
resolves in practically all cases close to the first year of
life; FPIES is dealt with more conservatively, neverthe-
less, it also resolves in most cases before the age of
5 years. All studies focusing on IgE mediated CMA have
demonstrated a time-dependent decrease of prevalence
due to the development of tolerance in increasing pro-
portions of the relevant populations. Epidemiological
studies have also been ubiquitous in confirming that, in
contrast to childhood, cases of IgE-CMA in adults are
very rare. Although it is not clear whether such cases
have a childhood onset, there is no doubt that only a
handful of pediatric patients will continue to suffer post
adolescence. Nevertheless, it has been put forward that
CMA may currently last longer than previously sug-
gested, with proportions developing tolerance at school
age dropping from ~90% to ~40% in the two most cited
studies. In order to inform such discussion, factors that
may affect the natural history should be taken into
account. These include, but are not confined to, severity
of the disease, pattern of IgE sensitization and events
relevant to antigen exposure. The infant diet may be
crucial, however, few studies have addressed the effects
of different variations of it on natural history. A consid-
erable proportion of CMA children may tolerate par-
tially hydrolyzed and/or heated milk, however the effects
of these on the natural history are not clear. Finally, sev-
eral successful attempts to introduce CM in the context
of SOTI protocols, seems to be able to permit milk con-
sumption in these children, while inducing tolerance in
some.
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